{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:48:19Z","timestamp":1791920899168,"version":"4.3.4"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T00:00:00Z","timestamp":1491868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"VA Merit","award":["110BX001894-01"],"award-info":[{"award-number":["110BX001894-01"]}]},{"name":"VA Merit","award":["AI100809"],"award-info":[{"award-number":["AI100809"]}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI068636"],"award-info":[{"award-number":["U01AI068636"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Several lines of evidence support the concept that NK cells play an important role in control of hepatitis C virus (HCV) infection via cytokine secretion and cytotoxicity. IL-7 is a homeostatic cytokine with a role in T cell development, activation, proliferation, and cytokine secretion. The IL-7R\u03b1 chain [cluster of differentiation (CD)127] is expressed on NK cells, with greatest abundance on the CD56brightCD16dim\/\u2212 (CD56bright) subset. Here, we measured CD127 expression on CD56bright, CD56dimCD16+ (CD56dim), or CD56negCD16+ (CD56neg) NK cell subsets of 25 uninfected donors (UD); 34 chronic HCV-infected, treatment-nai\u00fcve; 25 HIV-infected, virally suppressed on antiretroviral therapy (ART); and 42 HCV\u2013HIV-coinfected subjects on ART. Interestingly, CD127 expression on CD56bright NK cells negatively correlated with HCV plasma levels in HCV monoinfection and HCV\u2013HIV coinfection. IL-7 induced CD69 expression, as well as IFN-\u03b3 production, in CD56bright NK cells and also enhanced the IFN-\u03b1-induced CD69 expression on these cells. The latter was impaired in HIV infection. Furthermore, IL-7 induced B cell lymphoma 2 (BCL-2) expression and cell cycling of CD56bright NK cells, and this effect was impaired in HCV- and HIV-infected subjects. Whereas IL-7-stimulated CD56bright NK cell degranulation appeared intact in all cohorts, we observed impaired IL-7-activated NK cell cytolytic function in HCV- and HIV-infected subjects. Finally, IL-7-induced phosphorylation of STAT-5 (pSTAT-5) signaling was impaired in NK cells of subjects with chronic viral infection, and this was reversible upon 6 mo of viral suppression with IFN-free HCV therapy. These results implicate that IL-7-dependent NK cell activation and effector function may be other host immune surveillance mechanisms that are impaired in viral infections.<\/jats:p>","DOI":"10.1189\/jlb.5a1116-456r","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:30:18Z","timestamp":1491957018000},"page":"171-184","source":"Crossref","is-referenced-by-count":28,"title":["CD56bright NK IL-7R\u03b1 expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections"],"prefix":"10.1093","volume":"102","author":[{"given":"Chelsey J","family":"Judge","sequence":"first","affiliation":[{"name":"Department of Pathology, Cleveland VA Medical Center, Case Western Reserve University , Cleveland, Ohio, USA"},{"name":"Department of Medicine, University Hospitals Case Medical Center and Center for AIDS Research (CFAR), Case Western Reserve University , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenche","family":"Kostadinova","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospitals Case Medical Center and Center for AIDS Research (CFAR), Case Western Reserve University , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E","family":"Sherman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cincinnati Medical Center , Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel A","family":"Butt","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, New York, New York , USA"},{"name":"Hamad Healthcare Quality Institute and Hamad Medical Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland VA Medical Center, Case Western Reserve University , Cleveland, Ohio, USA"},{"name":"Department of Medicine, University Hospitals Case Medical Center and Center for AIDS Research (CFAR), Case Western Reserve University , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T","family":"Funderburg","sequence":"additional","affiliation":[{"name":"School of Health and Rehabilitation, Division of Medical Laboratory Science, The Ohio State University , Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L","family":"Landay","sequence":"additional","affiliation":[{"name":"Rush University Medical Center , Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M","family":"Lederman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospitals Case Medical Center and Center for AIDS Research (CFAR), Case Western Reserve University , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott F","family":"Sieg","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospitals Case Medical Center and Center for AIDS Research (CFAR), Case Western Reserve University , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan K","family":"Sandberg","sequence":"additional","affiliation":[{"name":"Center for Infection Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald D","family":"Anthony","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland VA Medical Center, Case Western Reserve University , Cleveland, Ohio, USA"},{"name":"Department of Medicine, University Hospitals Case Medical Center and Center for AIDS Research (CFAR), Case Western Reserve University , Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"key":"2023013012231371800_B1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2023013012231371800_B2","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1053\/jtls.2003.50246","article-title":"New approaches and therapeutic modalities for the prevention and treatment of recurrent HCV after liver transplantation","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl."},{"key":"2023013012231371800_B3","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2023013012231371800_B4","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/hep.27340","article-title":"Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response","volume":"60","author":"Bichoupan","year":"2014","journal-title":"Hepatology"},{"key":"2023013012231371800_B5","doi-asserted-by":"crossref","first-page":"e1003772","DOI":"10.1371\/journal.pcbi.1003772","article-title":"Modeling viral evolutionary dynamics after telaprevir-based treatment","volume":"10","author":"Haseltine","year":"2014","journal-title":"PLOS Comput. Biol."},{"key":"2023013012231371800_B6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.27053","article-title":"All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-na\u00efve patients with genotype 1 HCV infection","volume":"60","author":"Wyles","year":"2014","journal-title":"Hepatology"},{"key":"2023013012231371800_B7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/clinids\/23.5.1117","article-title":"Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections","volume":"23","author":"Zylberberg","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"2023013012231371800_B8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/319747","article-title":"Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine\/Infectious Diseases, in 1995 and 1997","volume":"32","author":"Cacoub","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"2023013012231371800_B9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/321819","article-title":"Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection","volume":"33","author":"Monga","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"2023013012231371800_B10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"2023013012231371800_B11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/jhep.2001.26517","article-title":"Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy","volume":"34","author":"Benhamou","year":"2001","journal-title":"Hepatology"},{"key":"2023013012231371800_B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.4CE0114-032R","article-title":"Editorial: NK cell immune activation in HIV-1 infection: flipping the bad and good side of the same coin","volume":"96","author":"Lugli","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"2023013012231371800_B13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1586\/eci.12.71","article-title":"Natural killer cells in hepatitis C virus infection","volume":"8","author":"Bozzano","year":"2012","journal-title":"Expert Rev. Clin. Immunol."},{"key":"2023013012231371800_B14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"key":"2023013012231371800_B15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"2023013012231371800_B16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng2035","article-title":"Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1","volume":"39","author":"Martin","year":"2007","journal-title":"Nat. Genet."},{"key":"2023013012231371800_B17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.it.2010.08.003","article-title":"CD56 negative NK cells: origin, function, and role in chronic viral disease","volume":"31","author":"Bj\u00f6rkstr\u00f6m","year":"2010","journal-title":"Trends Immunol."},{"key":"2023013012231371800_B18","doi-asserted-by":"crossref","first-page":"12365","DOI":"10.1128\/JVI.79.19.12365-12374.2005","article-title":"Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections","volume":"79","author":"Meier","year":"2005","journal-title":"J. Virol."},{"key":"2023013012231371800_B19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"2023013012231371800_B20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ni1106-1134","article-title":"IL-7 and the thymus dictate the NK cell \u2018labor market\u2019","volume":"7","author":"Smyth","year":"2006","journal-title":"Nat. Immunol."},{"key":"2023013012231371800_B21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2006.05.002","article-title":"Natural killer cells as an initial defense against pathogens","volume":"18","author":"Lodoen","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"2023013012231371800_B22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.trim.2006.09.019","article-title":"Multi-directional cross-regulation of NK cell function during innate immune responses","volume":"17","author":"Marcenaro","year":"2006","journal-title":"Transpl. Immunol."},{"key":"2023013012231371800_B23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/infdis\/jit677","article-title":"Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon\/ribavirin therapy in chronic HCV infection","volume":"209","author":"Meng","year":"2014","journal-title":"J. Infect. Dis."},{"key":"2023013012231371800_B24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2009.08.066","article-title":"Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner","volume":"138","author":"Ahlenstiel","year":"2010","journal-title":"Gastroenterology"},{"key":"2023013012231371800_B25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12090","article-title":"Natural killer cells: multifaceted players with key roles in hepatitis C immunity","volume":"255","author":"Golden-Mason","year":"2013","journal-title":"Immunol. Rev."},{"key":"2023013012231371800_B26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T cells","volume":"481","author":"Waggoner","year":"2011","journal-title":"Nature"},{"key":"2023013012231371800_B27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2567.2009.03244.x","article-title":"Interleukin-7 promotes the survival of human CD4+ effector\/memory T cells by up-regulating Bcl-2 proteins and activating the JAK\/STAT signalling pathway","volume":"130","author":"Chetoui","year":"2010","journal-title":"Immunology"},{"key":"2023013012231371800_B28","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1182\/blood-2010-12-323600","article-title":"Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance","volume":"118","author":"Hodge","year":"2011","journal-title":"Blood"},{"key":"2023013012231371800_B29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.21365","article-title":"Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence","volume":"44","author":"Golden-Mason","year":"2006","journal-title":"Hepatology"},{"key":"2023013012231371800_B30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2893.2012.01618.x","article-title":"Persistent hepatitis C virus (HCV) infection impairs HCV-specific cytotoxic T cell reactivity through Mcl-1\/Bim imbalance due to CD127 down-regulation","volume":"20","author":"Larrubia","year":"2013","journal-title":"J. Viral Hepat."},{"key":"2023013012231371800_B31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/CJI.0b013e3181cd872d","article-title":"IL-7 enhances survival of human CD56bright NK cells","volume":"33","author":"Michaud","year":"2010","journal-title":"J. Immunother."},{"key":"2023013012231371800_B32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"2023013012231371800_B33","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.4049\/jimmunol.0903758","article-title":"Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection","volume":"184","author":"Crawley","year":"2010","journal-title":"J. Immunol."},{"key":"2023013012231371800_B34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/clim.2001.5018","article-title":"ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producing peripheral blood lymphocytes in infected humans with and without cirrhosis","volume":"99","author":"Anthony","year":"2001","journal-title":"Clin. Immunol."},{"key":"2023013012231371800_B35","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1128\/JVI.02671-08","article-title":"Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells","volume":"83","author":"Liang","year":"2009","journal-title":"J. Virol."},{"key":"2023013012231371800_B36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/jir.2013.0075","article-title":"Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis","volume":"34","author":"Landi","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"2023013012231371800_B37","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood.V99.11.3892","article-title":"Interleukin-7: from bench to clinic","volume":"99","author":"Fry","year":"2002","journal-title":"Blood"},{"key":"2023013012231371800_B38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2014.08.618","article-title":"Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis","volume":"276","author":"Su","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"2023013012231371800_B39","doi-asserted-by":"crossref","first-page":"11175","DOI":"10.1128\/JVI.00753-09","article-title":"Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function","volume":"83","author":"Conry","year":"2009","journal-title":"J. Virol."},{"key":"2023013012231371800_B40","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.78.11.6033-6042.2004","article-title":"Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity","volume":"78","author":"Lum","year":"2004","journal-title":"J. Virol."},{"key":"2023013012231371800_B41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1189\/jlb.0710430","article-title":"IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection","volume":"89","author":"Vranjkovic","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"2023013012231371800_B42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1189\/jlb.4MR0314-141R","article-title":"Innate immune cell networking in hepatitis C virus infection","volume":"96","author":"Saha","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"2023013012231371800_B43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/lt.22080","article-title":"Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation","volume":"16","author":"Moroso","year":"2010","journal-title":"Liver Transpl."},{"key":"2023013012231371800_B44","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/eji.201646559","article-title":"Tissue-resident Eomes (hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver","volume":"46","author":"Harmon","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"2023013012231371800_B45","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0264-410X(03)00197-X","article-title":"Human natural killer cell function and their interactions with dendritic cells","volume":"21","author":"Moretta","year":"2003","journal-title":"Vaccine"},{"key":"2023013012231371800_B46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nri1088","article-title":"What does it take to make a natural killerarticle-title","volume":"3","author":"Colucci","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"2023013012231371800_B47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20021836","article-title":"Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice","volume":"197","author":"Koka","year":"2003","journal-title":"J. Exp. Med."},{"key":"2023013012231371800_B48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/QAI.0b013e3181d0c5b4","article-title":"Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers","volume":"53","author":"Vieillard","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"2023013012231371800_B49","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.4049\/jimmunol.180.6.3637","article-title":"Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences","volume":"180","author":"Golden-Mason","year":"2008","journal-title":"J. Immunol."},{"key":"2023013012231371800_B50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2276","article-title":"Evolutionary struggles between NK cells and viruses","volume":"8","author":"Lanier","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2023013012231371800_B51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/jiu125","article-title":"Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease","volume":"210","author":"Shive","year":"2014","journal-title":"J. Infect. Dis."},{"key":"2023013012231371800_B52","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.188.11.2067","article-title":"Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity","volume":"188","author":"Imada","year":"1998","journal-title":"J. Exp. Med."},{"key":"2023013012231371800_B53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2012-304377","article-title":"Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes","volume":"63","author":"Larrea","year":"2014","journal-title":"Gut"},{"key":"2023013012231371800_B54","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s00109-005-0684-y","article-title":"Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis","volume":"83","author":"Booth","year":"2005","journal-title":"J. Mol. Med. (Berl.)"},{"key":"2023013012231371800_B55","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ng2106","article-title":"Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis","volume":"39","author":"Lundmark","year":"2007","journal-title":"Nat. Genet."},{"key":"2023013012231371800_B56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-015-0577-y","article-title":"Association between IL7R polymorphisms and severe liver disease in HIV\/HCV coinfected patients: a cross-sectional study","volume":"13","author":"Guzm\u00e1n-Fulgencio","year":"2015","journal-title":"J. Transl. Med."},{"key":"2023013012231371800_B57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/102\/1\/171\/48169365\/jlb0171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/102\/1\/171\/48169365\/jlb0171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T13:36:37Z","timestamp":1677504997000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/102\/1\/171\/6935396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,4,11]]},"published-print":{"date-parts":[[2017,4,11]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.5a1116-456r","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7]]},"published":{"date-parts":[[2017,4,11]]}}}